MATTE', Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 3.727
EU - Europa 3.190
AS - Asia 2.367
SA - Sud America 385
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 72
OC - Oceania 12
Totale 9.866
Nazione #
US - Stati Uniti d'America 3.586
RU - Federazione Russa 1.261
SG - Singapore 880
CN - Cina 688
GB - Regno Unito 655
IT - Italia 379
BR - Brasile 309
VN - Vietnam 286
HK - Hong Kong 189
SE - Svezia 175
FR - Francia 153
DE - Germania 142
IE - Irlanda 142
FI - Finlandia 110
KR - Corea 61
CA - Canada 58
JP - Giappone 53
UA - Ucraina 42
ID - Indonesia 40
IN - India 34
AR - Argentina 33
MX - Messico 29
NL - Olanda 25
AT - Austria 23
BD - Bangladesh 21
BE - Belgio 17
TR - Turchia 16
NG - Nigeria 15
EC - Ecuador 14
ES - Italia 13
EG - Egitto 12
PL - Polonia 12
AU - Australia 11
IQ - Iraq 11
PK - Pakistan 10
UZ - Uzbekistan 10
ZA - Sudafrica 10
MA - Marocco 9
TW - Taiwan 9
GR - Grecia 8
TT - Trinidad e Tobago 8
BJ - Benin 7
CL - Cile 7
CR - Costa Rica 7
NI - Nicaragua 7
VE - Venezuela 7
CO - Colombia 6
LT - Lituania 6
PR - Porto Rico 6
CW - ???statistics.table.value.countryCode.CW??? 5
CZ - Repubblica Ceca 5
IL - Israele 5
JO - Giordania 5
NP - Nepal 5
OM - Oman 5
PH - Filippine 5
TG - Togo 5
CH - Svizzera 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MY - Malesia 4
PY - Paraguay 4
SV - El Salvador 4
AL - Albania 3
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
SA - Arabia Saudita 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EU - Europa 2
GP - Guadalupe 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
PA - Panama 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
IR - Iran 1
KE - Kenya 1
LI - Liechtenstein 1
LV - Lettonia 1
Totale 9.746
Città #
Ashburn 556
Southend 538
Singapore 454
Moscow 430
Chandler 340
San Jose 330
Dallas 261
Jacksonville 189
Hong Kong 184
Verona 173
Ann Arbor 154
Dublin 142
Beijing 139
Council Bluffs 120
Houston 94
The Dalles 83
Woodbridge 78
Wilmington 69
New York 68
Ho Chi Minh City 67
Los Angeles 62
Dong Ket 57
Lawrence 50
Princeton 50
Jinan 48
Tokyo 47
Hanoi 39
Nanjing 39
Helsinki 37
Jakarta 36
São Paulo 34
Hebei 32
Shenyang 31
Santa Clara 30
Milan 29
Buffalo 28
Munich 28
Seattle 22
Boardman 19
Columbus 19
Lancaster 19
London 19
Redondo Beach 19
Collegeville 18
Falls Church 18
Ningbo 18
Brussels 17
Changsha 17
Hangzhou 17
Redmond 17
Sindelfingen 17
Montreal 16
Nanchang 16
Orem 16
Turku 16
Vienna 16
Zhengzhou 16
Guangzhou 15
Rome 15
Tianjin 15
Nuremberg 14
Chicago 12
Frankfurt am Main 12
San Francisco 12
Taiyuan 12
Abuja 11
Atlanta 11
Toronto 11
Campinas 10
Haikou 10
Jiaxing 10
Stockholm 10
Warsaw 10
Bologna 9
Brooklyn 9
Chennai 9
Manchester 9
Taizhou 9
Washington 9
Cleveland 8
Mexico City 8
Tashkent 8
Baghdad 7
Belo Horizonte 7
Cotonou 7
Denver 7
Haiphong 7
Johannesburg 7
Lanzhou 7
Managua 7
Phoenix 7
Redwood City 7
Boston 6
Cagliari 6
Cairo 6
Cambridge 6
Catanzaro 6
Detroit 6
Dongguan 6
Guayaquil 6
Totale 5.884
Nome #
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 304
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 287
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 278
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 252
Two-photon microscopy imaging of thy1GFP-M transgenic mice: a novel animal model to investigate brain dendritic cell subsets in vivo 237
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 236
Integrated proteomic analysis of normal and diseased red cells. Role of physiological stresses in erythrocyte signaling pathways 231
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis 228
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 224
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 209
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band3 204
The interplay between peroxiredoxin-2 and Nrf2 is important in limiting oxidative mediated dysfunction in b-thalassemic erythropoiesis 201
New Therapeutic Options for the Treatment of Sickle Cell Disease. 201
NCOA4 Deficiency Impairs Systemic Iron Homeostasis 200
IN ChAc RED CELLS THE ABNORMALLY ACTIVATED LYN AFFECTS ANKYRIN MULTIPROTEIN COMPLEXES AND IS INHIBITED BY DASATINIB 197
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity 195
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 195
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 193
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 191
Heat shock protein-27, 70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidences from transgenic sickle cell mouse model 190
Oxidative stress and b-thalasssemic erythroid cells behind the molecular defect 188
Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk 187
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 182
S-nitrosylation of peroxiredoxin II E promotes peroxynitrite-mediated tyrosine nitration 181
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice 179
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 179
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 178
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease 176
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 171
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 166
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II 162
Proteomic and functional analysis of tyrosinephosphorylated red cell membrane proteins in mouse lacking SRC-family-kinases 162
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 155
Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease 154
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. 153
Effects of hypoxia–reoxygenation stimuli on renal redox status and nuclear factor erythroid 2-related factor 2 pathway in sickle cell SADmice 153
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 150
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 149
Oxidation and erythropoiesis 147
Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase 147
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease 146
An Oral Carbon Monoxide-Releasing Molecule Protects against Acute Hyper-hemolysis in Sickle Cell Disease 145
The Novel Role That Nrf2 Plays in Erythropoiesis during Aging 145
Performance of a novel sieving matrix of Poly(vinyl alcohol)ACRYLAMIDE copolymer in elecrophoretic separations of high molecular weight proteins from red cell membrane. 144
Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells 142
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 142
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia 142
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 140
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. 139
Peroxiredoxin-2 (Prx2) expression is increased in beta thalassemic mouse red cells but displaced from the membrane as marker of oxidative stress 136
Pesticide toxicogenomics across scales: in vitro transcriptome predicts mechanisms and outcomes of exposure in vivo 129
Red Blood Cell Homeostasis: Pharmacological Interventions to Explore Biochemical, Morphological and Mechanical Properties. 119
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders 118
Mitapivat metabolically reprograms human beta-thalassemic erythroblasts, increasing their responsiveness to oxidation 104
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder 98
Pharmacological Inhibition of Calpain-1 Prevents Red Cell Dehydration and Reduces Gardos Channel Activity in a Mouse Model of Sickle Cell Disease. Identification of Druggable Protease Target 57
PEROXIREDOXIN-2 (Prx2) MEMBRANE DISPLACEMENT IS A NEW ADDITIONAL FACTOR to the SEVERITY of beta-THALASSEMIC MOUSE RED CELL MEMBRANE DAMAGE 48
Totale 9.866
Categoria #
all - tutte 31.892
article - articoli 27.312
book - libri 0
conference - conferenze 4.025
curatela - curatele 0
other - altro 555
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022268 0 0 0 34 21 11 14 25 35 17 18 93
2022/2023983 62 132 82 150 90 240 8 37 98 33 32 19
2023/2024536 22 40 39 61 66 78 25 35 9 14 109 38
2024/20251.426 76 64 49 242 77 96 129 69 209 81 100 234
2025/20263.805 264 176 246 572 1.069 274 368 202 235 248 49 102
2026/2027667 39 82 143 403 0 0 0 0 0 0 0 0
Totale 9.866